Predictive value of triglyceride-glucose index for the evaluation of coronary artery disease severity and occurrence of major adverse cardiovascular events
The triglyceride-glucose (TyG) index has been proposed as an independent predictor of coronary artery disease (CAD). In this retrospective study, we further examine this association and its utility as a predictor for major adverse cardiovascular events (MACE). A total of 870 patients who underwent coronary angiography between May 2008 and June 2009 were included in this retrospective study. The TyG index was calculated using the formula Ln [fasting TG (mg/dL) × FBG (mg/dL)/2]. The association of the TyG index with the presence and severity of CAD, cardiovascular risk factors, and inflammatory markers was evaluated at baseline. In the longitudinal study, the multivariate-adjusted Cox hazard model was used to investigate the associations of the TyG index with the occurrence of MACE during a 5-yr follow-up, which was defined as the endpoint. The TyG index was significantly associated with the presence and severity of CAD. Multiple linear regression analysis showed that a high TyG index, together with inflammatory markers and dyslipidemia, was independently associated with greater stenotic occlusion of coronary arteries (adjusted <i>R</i><sup>2</sup> = 0.031, <i>P</i> < 0.001). Kaplan-Meier survival curve (free of MACE) by tertiles of the TyG index showed a higher incidence of MACE in the upper tertile (log-rank test, <i>P</i> = 0.02). Multivariate Cox analysis demonstrated that the risk of incident MACE during the follow-up was associated with higher levels of the TyG index, even after adjusting for inflammatory parameters and cardiovascular risk factors: hazard ratio = 1.54 (95% confidence interval: 1.18-2.13; <i>P</i> < 0.01). We conclude that an elevated TyG index is independently associated with a higher risk of CAD and a poor prognosis for MACE.<b>NEW & NOTEWORTHY</b> This retrospective study demonstrates significant associations between the TyG index and the occurrence and severity of CAD, as well as indicates the clinical value of the TyG index as a potential predictor for MACE.
Authors
- Carolina Hernández-Carballo (ORCID: https://orcid.org/0009-0001-9177-8103)
- Ernesto Martín‐Núñez (ORCID: https://orcid.org/0000-0003-0341-0956)
- Alberto Martín-Olivera (ORCID: https://orcid.org/0009-0009-9805-0965)
- Juan F. Navarro‐González (ORCID: https://orcid.org/0000-0002-5015-7474)
- Ainhoa González-Luis
- Javier Donate‐Correa (ORCID: https://orcid.org/0000-0001-7389-7347)
- Carmen Mora‐Fernández (ORCID: https://orcid.org/0000-0003-1570-6332)
- Orlando Siverio-Morales
Institutions
- Universidad de La Laguna (ES)
- Universidad Pública de Navarra (UPNA) (ES)
- Instituto de Salud Carlos III (ES)
- Hospital Universitario Nuestra Señora de Candelaria (ES)
- Sociedad Española de Nefrología (ES)
- Navarre Institute of Health Research (ES)
- Navarrabiomed (ES)
Publication Details
- Journal
- American Journal of Physiology-Heart and Circulatory Physiology
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1152/ajpheart.00684.2024
- Citations
- 8
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 2.86
Funders
- Universidad de La Laguna
- Instituto de Salud Carlos III